ArticleMedical oncology (Northwood, London, England)2026
Design and evaluation of an EpCAM-specific peptide-diphtheria toxin fusion (DT-SNFYMPL) for targeted epithelial cancer treatment.
Sara Rafia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.